Literature DB >> 31449780

Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic cell transplantation program (Part I): Minimum requirements and beyond.

Marcelo C Pasquini1, Alok Srivastava2, Syed Osman Ahmed3, Mahmoud Aljurf3, Yoshiko Atsuta4, Carol Doleysh5, Sebastian Galeano6, Eliane Gluckman7, Hildegard Greinix8, Gregory Hale9, Parameswaran Hari5, Shahrukh K Hashmi3, Naynesh Kamani10, Mary J Laughlin11, Dietger Niederwieser12, Adriana Seber13, Jeffrey Szer14, John A Snowden15, Koen Van Biesen16, Paula Watry5, Daniel J Weisdorf17, Jane Apperley18.   

Abstract

Hematopoietic cell transplantation (HCT) is a highly complex procedure that requires a dedicated multidisciplinary team to optimize its safety. In addition, institutions may have different needs regarding indications based on regional disease prevalence or may have an interest in developing specialized services. Yet, structured recommendations are not commonly available. Here, the Transplant Center and Recipient Issues Standing Committee for the Worldwide Network for Blood and Marrow Transplantation (WBMT) organized a structured review of all pertinent elements to establish a transplant program. First, we solicited components from committee members and grouped them in domains (infrastructure, staff, cell processing laboratory, blood banking, laboratory, radiology, pharmacy, HLA testing, ancillary services and quality). Subsequently, reviewers scored all elements on a 7-point scale, from an absolute requirement (score of 1) to not required (score of 7). An independent group of five experienced transplant physicians reviewed the rankings. Minimum requirements to establish any HCT program were identified among elements with mean score of ≤2.0, and specific elements for allogeneic and autologous HCT were identified. Mean scores >2.0-4.0 were classified as preferred recommendation, and mean scores of >4.0 to ≤7.0 were considered ideal recommendations for advanced and complex types of transplantation. This structured set of recommendations guides the prioritization of minimum requirements to establish a transplant program and to set the path for expansion and further development.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Autologous vs. allogeneic transplants; Transplant program requirements

Mesh:

Year:  2019        PMID: 31449780      PMCID: PMC7125509          DOI: 10.1016/j.hemonc.2019.08.001

Source DB:  PubMed          Journal:  Hematol Oncol Stem Cell Ther


  14 in total

1.  Results of an autologous noncryopreserved, unmanipulated peripheral blood hematopoietic stem cell transplant program: a single-institution, 10-year experience.

Authors:  Guillermo J Ruiz-Argüelles; David Gómez-Rangel; Guillermo J Ruiz-Delgado; Alejandro Ruiz-Argüelles; Beatriz Pérez-Romano; Liliana Rivadeneyra
Journal:  Acta Haematol       Date:  2003       Impact factor: 2.195

2.  Hematopoietic stem cell transplantation: a global perspective.

Authors:  Alois Gratwohl; Helen Baldomero; Mahmoud Aljurf; Marcelo C Pasquini; Luis Fernando Bouzas; Ayami Yoshimi; Jeff Szer; Jeff Lipton; Alvin Schwendener; Michael Gratwohl; Karl Frauendorfer; Dietger Niederwieser; Mary Horowitz; Yoshihisa Kodera
Journal:  JAMA       Date:  2010-04-28       Impact factor: 56.272

Review 3.  Hematopoietic stem-cell transplantation.

Authors:  Edward A Copelan
Journal:  N Engl J Med       Date:  2006-04-27       Impact factor: 91.245

Review 4.  Hematopoietic stem cell transplantation in Egypt.

Authors:  Hk Mahmoud; Am El-Haddad; Oa Fahmy; M El-Emary; A Nassar; M Abdel-Mooti; A Sobhy; A Sultan
Journal:  Bone Marrow Transplant       Date:  2008-08       Impact factor: 5.483

5.  Allogeneic bone marrow transplantation in the developing world: experience from a center in India.

Authors:  M Chandy; A Srivastava; D Dennison; V Mathews; B George
Journal:  Bone Marrow Transplant       Date:  2001-04       Impact factor: 5.483

Review 6.  Important drug interactions in hematopoietic stem cell transplantation: what every physician should know.

Authors:  Brett Glotzbecker; Christine Duncan; Edwin Alyea; Bonnie Campbell; Robert Soiffer
Journal:  Biol Blood Marrow Transplant       Date:  2011-12-07       Impact factor: 5.742

7.  Latin America: the next region for haematopoietic transplant progress.

Authors:  G Jaimovich; J Martinez Rolon; H Baldomero; M Rivas; I Hanesman; L Bouzas; C Bonfim; J Palma; A Kardus-Urueta; D Ubidia; W Bujan-Boza; O Gonzalez-Ramella; G Ruiz-Argüelles; D Gomez-Almaguer; G Espino; E Fanilla; D Gonzalez; A Carrasco; S Galeano; G Borelli; M Hernandez-Gimenez; M Pasquini; Y Kodera; A Gratwohl; M Gratwohl; J Nuñez; J Szer; R P Gale; D Niederwieser; A Seber
Journal:  Bone Marrow Transplant       Date:  2017-01-23       Impact factor: 5.483

8.  Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends.

Authors:  Helen Baldomero; Mahmoud Aljurf; Syed Z A Zaidi; Shahrukh K Hashmi; Ardeshir Ghavamzadeh; Alaa Elhaddad; Rose-Marie Hamladji; Parvez Ahmed; Lamia Torjemane; Miguel Abboud; Abdelghani Tbakhi; Murtadha Al Khabori; Asma El Quessar; Nosa Bazuaye; Mohamed Amine Bekadja; Salman Adil; Omar Fahmy; Mani Ramzi; Ahmed Ibrahim; Amal Alseraihy; Nour Ben Abdejalil; Mahmoud Sarhan; Mohammed Al Huneini; Lahoucine Mahmal; Hassan ElSolh; Fazal Hussain; Amr Nassar; Hani Al-Hashmi; Amir Ali Hamidieh; Marcelo Pasquini; Yoshihisa Kodera; Nicolaus Kröger; Mohamed Mohty; Gregorio Jaimovich; Juliana Martinez Rolon; Kristjan Paulson; Hildegard Greinix; Daniel Weisdorf; Mary Horowitz; José Nunez; Alois Gratwohl; Jacob Passweg; Mickey Koh; Jeff Szer; Dietger Niederwieser; Nicolas Novitzky
Journal:  Bone Marrow Transplant       Date:  2018-08-06       Impact factor: 5.483

9.  Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey.

Authors:  D Niederwieser; H Baldomero; J Szer; M Gratwohl; M Aljurf; Y Atsuta; L F Bouzas; D Confer; H Greinix; M Horowitz; M Iida; J Lipton; M Mohty; N Novitzky; J Nunez; J Passweg; M C Pasquini; Y Kodera; J Apperley; A Seber; A Gratwohl
Journal:  Bone Marrow Transplant       Date:  2016-02-22       Impact factor: 5.483

10.  Twenty years of experience on stem cell transplantation in iran.

Authors:  Ardeshir Ghavamzadeh; Kamran Alimoghaddam; Fatemeh Ghaffari; Roshanak Derakhshandeh; Arash Jalali; Mohammad Jahani
Journal:  Iran Red Crescent Med J       Date:  2013-02-05       Impact factor: 0.611

View more
  2 in total

1.  Increasing access to allogeneic hematopoietic cell transplant: an international perspective.

Authors:  Vanderson Rocha; Giancarlo Fatobene; Dietger Niederwieser
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

2.  One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors.

Authors:  Dietger Niederwieser; Helen Baldomero; Nosa Bazuaye; Caitrin Bupp; Naeem Chaudhri; Selim Corbacioglu; Alaa Elhaddad; Cristóbal Frutos; Sebastian Galeano; Nada Hamad; Amir Ali Hamidieh; Shahrukh Hashmi; Aloysius Ho; Mary M Horowitz; Minako Iida; Gregorio Jaimovich; Amado Karduss; Yoshihisa Kodera; Nicolaus Kröger; Regis Péffault de Latour; Jong Wook Lee; Juliana Martínez-Rolón; Marcelo C Pasquini; Jakob Passweg; Kristjan Paulson; Adriana Seber; John A Snowden; Alok Srivastava; Jeff Szer; Daniel Weisdorf; Nina Worel; Mickey B C Koh; Mahmoud Aljurf; Hildegard Greinix; Yoshiko Atsuta; Wael Saber
Journal:  Haematologica       Date:  2022-05-01       Impact factor: 11.047

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.